Back to Search Start Over

Cross-reactivity of glycan-reactive HIV-1 broadly neutralizing antibodies with parasite glycans

Authors :
Medical Research Council (UK)
Rosetrees Trust
Fondation Dormeur, Vaduz
National Institute for Health Research (UK)
NIHR Biomedical Research Centre (UK)
NHS Foundation Trust
Kings College London
Ministerio de Educación y Ciencia (España)
Agencia Estatal de Investigación (España)
Wellcome Trust
Ministerio de Ciencia, Innovación y Universidades (España)
Biotechnology and Biological Sciences Research Council (UK)
Bill & Melinda Gates Foundation
Ministry of Foreign Affairs (Denmark)
Irish Aid
World Bank Group
Ministry of Foreign Affairs (The Netherlands)
Norwegian Agency for Development Cooperation
European Commission
Department for International Development (UK)
United States Agency for International Development
Huettner, Isabella
Krumm, Stefanie A.
Serna, Sonia
Brzezicka, Katarzyna
Monaco, Serena
Walpole, Samuel
van Diepen, Angela
Allan, Fiona
Hicks,Thomas
Kimuda, Simon
Emery, Aidan M.
Landais, Elise
Hokke, Cornelis H.
Angulo, Jesús
Reichardt, Niels
Doores, Katie J
Medical Research Council (UK)
Rosetrees Trust
Fondation Dormeur, Vaduz
National Institute for Health Research (UK)
NIHR Biomedical Research Centre (UK)
NHS Foundation Trust
Kings College London
Ministerio de Educación y Ciencia (España)
Agencia Estatal de Investigación (España)
Wellcome Trust
Ministerio de Ciencia, Innovación y Universidades (España)
Biotechnology and Biological Sciences Research Council (UK)
Bill & Melinda Gates Foundation
Ministry of Foreign Affairs (Denmark)
Irish Aid
World Bank Group
Ministry of Foreign Affairs (The Netherlands)
Norwegian Agency for Development Cooperation
European Commission
Department for International Development (UK)
United States Agency for International Development
Huettner, Isabella
Krumm, Stefanie A.
Serna, Sonia
Brzezicka, Katarzyna
Monaco, Serena
Walpole, Samuel
van Diepen, Angela
Allan, Fiona
Hicks,Thomas
Kimuda, Simon
Emery, Aidan M.
Landais, Elise
Hokke, Cornelis H.
Angulo, Jesús
Reichardt, Niels
Doores, Katie J
Publication Year :
2022

Abstract

The HIV-1 Envelope glycoprotein (Env) is the sole target for broadly neutralizing antibodies (bnAbs). Env is heavily glycosylated with host-derived N-glycans, and many bnAbs bind to, or are dependent upon, Env glycans for neutralization. Although glycan-binding bnAbs are frequently detected in HIV-infected individuals, attempts to elicit them have been unsuccessful because of the poor immunogenicity of Env N-glycans. Here, we report cross-reactivity of glycan-binding bnAbs with self- and non-self N-glycans and glycoprotein antigens from different life-stages of Schistosoma mansoni. Using the IAVI Protocol C HIV infection cohort, we examine the relationship between S. mansoni seropositivity and development of bnAbs targeting glycan-dependent epitopes. We show that the unmutated common ancestor of the N332/V3-specific bnAb lineage PCDN76, isolated from an HIV-infected donor with S. mansoni seropositivity, binds to S. mansoni cercariae while lacking reactivity to gp120. Overall, these results present a strategy for elicitation of glycan-reactive bnAbs which could be exploited in HIV-1 vaccine development.

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1333183839
Document Type :
Electronic Resource